Sign in

CIK 0001651308 · Large accelerated filer

BeOne Medicines Ltd.

Sign in to watch
Ticker
BEIGF
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
981209416
Phone
41-616851900
Business address
C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
Former names
BeiGene, Ltd.

Securities

  • ONC American Depositary Shares Nasdaq
  • BEIGF Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$48,487,541
in 9 filings, $47.8M under 10b5-1 plans

Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Wang Xiaodong −$46.8M Director sold 100% of stake
  2. Lee Chan Henry −$865K SVP, General Counsel sold 100% of stake
  3. Ball Titus B. −$679K Principal Accounting Officer sold 100% of stake
  4. Wu Xiaobin −$106K President and COO sold 100% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-03-29 Huang Jane CMO, Hematology Option exercise · Share Option (Right to Buy) −19,500 266,075
2021-03-12 Glazer Donald W. Director Gift −80,000 2,827,829
2021-02-26 Huang Jane CMO, Hematology Option exercise +1,500 $29.49 $44K 1,500
2021-02-26 Huang Jane CMO, Hematology Sale −100 $315.62 $32K 1,400
2021-02-26 Huang Jane CMO, Hematology Sale −100 $317.52 $32K 1,300
2021-02-26 Huang Jane CMO, Hematology Sale −300 $319.67 $96K 1,000
2021-02-26 Huang Jane CMO, Hematology Sale −400 $321.21 $128K 600
2021-02-26 Huang Jane CMO, Hematology Sale −600 $322.33 $193K 0
2021-02-26 Huang Jane CMO, Hematology Option exercise · Share Option (Right to Buy) −19,500 285,575
2021-01-29 Huang Jane CMO, Hematology Option exercise +1,500 $29.49 $44K 1,500
2021-01-29 Huang Jane CMO, Hematology Sale −300 $318.48 $96K 1,200
2021-01-29 Huang Jane CMO, Hematology Sale −393 $319.61 $126K 807
2021-01-29 Huang Jane CMO, Hematology Sale −7 $320.81 $2K 800
2021-01-29 Huang Jane CMO, Hematology Sale −300 $322.51 $97K 500
2021-01-29 Huang Jane CMO, Hematology Sale −100 $323.85 $32K 400
2021-01-29 Huang Jane CMO, Hematology Sale −100 $326.58 $33K 300
2021-01-29 Huang Jane CMO, Hematology Sale −100 $330.05 $33K 200
2021-01-29 Huang Jane CMO, Hematology Sale −200 $331.46 $66K 0
2021-01-29 Huang Jane CMO, Hematology Option exercise · Share Option (Right to Buy) −19,500 305,075
2021-01-15 Liang Howard CFO & Chief Strategy Officer Option exercise +12,600 $6.50 $82K 12,600

Page 73 of 99 · 1,972 trades